Delamanid is an anti-tuberculosis agent derived from the nitro-dihydro-imidazooxazole class of compounds that inhibits mycolic acid synthesis of bacterial cell wall. It is used to treat multidrug-resistant and extensively drug-resistant tuberculosis in a combination regimen. Its therapeutic use is listed as anti-infectives, antibiotics and antituberculars. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Deltyba and Delamanidum. Its PubChem CID is 6480466.
Delamanid
| CAS No | 681492-22-8 |
|---|---|
| Molecular Formula | C25H25F3N4O6 |
| Molecular Weight | 534.5 g/mol |
| Synonyms | (2R)-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenoxy]methyl]-3H-imidazo[2,1-b][1,3]oxazole |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Delamanid is an anti-tuberculosis agent derived from the nitro-dihydro-imidazooxazole class of compounds that inhibits mycolic acid synthesis of bacterial cell wall.
The listed CAS number is 681492-22-8.
The listed molecular formula is C25H25F3N4O6.
The listed molecular weight is 534.5 g/mol.
(2R)-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenoxy]methyl]-3H-imidazo[2,1-b][1,3]oxazole.
The source lists Deltyba and Delamanidum.